Latest News

If you have been wondering whether Marsh & McLennan Companies at around US$173 a share is a fair deal or not, this article walks through what the current price might be implying about value. The stock has slipped around 0.8% over the last week, 0.5% over the last month and 5.1% year to date, with a 22.9% decline over the past year contrasted against 5.4% and 47.1% returns over the past 3 and 5 years. Recent news around Marsh & McLennan Companies has focused on the business as a major...

PDD Holdings’ Q4 2025 results, released in late March, showed earnings per share of 17.69 and revenue of CN¥123.91 billion, both below analyst expectations, amid pressure from competition, economic softness, and heavy supply chain investments. At the same time, the group is confronting heightened regulatory scrutiny in China and abroad, including investigations and potential changes to import duty rules that could affect its Temu platform and broader operations. We’ll now examine how this...

In a week marked by geopolitical tensions and energy market volatility, global markets saw significant movements, with major U.S. stock indexes finishing higher despite mixed economic signals. Smaller-cap indexes also posted solid gains, indicating potential opportunities in the small-cap sector as investors navigate through these uncertain times. In such a dynamic environment, identifying undervalued small-cap stocks can be particularly appealing to investors looking for growth potential...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

As global markets navigate the complexities of Middle East tensions and energy market volatility, major indices like the Nasdaq Composite have shown resilience with significant gains, reflecting a broader sentiment of cautious optimism amid geopolitical uncertainties. In this environment, identifying high growth tech stocks with promising global potential requires a focus on companies that demonstrate robust adaptability and innovation to thrive despite fluctuating economic conditions.

In a global market characterized by geopolitical tensions and energy volatility, investors are navigating through mixed signals in economic indicators and stock performances. As indices like the Nasdaq Composite and S&P 500 experience notable gains amid these uncertainties, the search for stocks that may be priced below their estimated value becomes increasingly relevant. Identifying such stocks often involves looking at companies with strong fundamentals that can weather current market...

As global markets navigate the complexities of Middle East tensions and energy market volatility, major indices like the Nasdaq Composite and S&P 500 have shown resilience with notable gains. Against this backdrop, investors often seek growth companies where high insider ownership can signal confidence in a company's future prospects.

Global markets have been navigating through a volatile period, with energy market fluctuations and geopolitical tensions in the Middle East capturing investor attention. Despite these challenges, major indices like the Nasdaq Composite and S&P 500 have posted gains, suggesting resilience amid uncertainty. In such an environment, penny stocks—often representing smaller or newer companies—can offer intriguing opportunities for investors seeking affordability alongside growth potential. While...

In recent weeks, global markets have been navigating a complex landscape marked by geopolitical tensions in the Middle East and fluctuating energy prices. Despite these challenges, smaller-cap indexes like the S&P MidCap 400 and Russell 2000 have shown resilience with solid gains, suggesting that opportunities may exist for discerning investors willing to explore beyond the usual suspects. In this environment, identifying promising stocks often involves looking for companies with strong...

As global markets navigate the complexities of Middle East tensions and energy market volatility, investors are paying close attention to economic indicators and geopolitical developments that influence stock performance. Amidst this backdrop, dividend stocks continue to attract interest for their potential to provide steady income streams, especially in times of uncertainty. A good dividend stock often exhibits strong fundamentals and a history of reliable payouts, making it an appealing...

Sugi HoldingsLtd (TSE:7649) has just released its FY 2026 numbers, with fourth quarter revenue of ¥260.2 billion and basic EPS of ¥51.47, capping a trailing twelve month period where revenue reached ¥1.0 trillion and basic EPS came in at ¥248.56. Over recent quarters, revenue has moved from ¥243.4 billion in Q4 FY 2025 to ¥260.2 billion in Q4 FY 2026, while basic EPS shifted from ¥36.60 to ¥51.47. This sets up a story where improving net profit margins and higher trailing earnings are the key...

Revenue beat and growth outlook put Standex International (SXI) in focus Standex International (SXI) is on investors’ radar after reporting a 16.6% year-on-year revenue increase that topped analyst expectations, coupled with guidance pointing to mid to high single digit organic growth. See our latest analysis for Standex International. Alongside the guidance update, the share price has climbed 14.92% over the past 90 days and the 1-year total shareholder return is 97.44%. This indicates that...

McDonald’s (NYSE:MCD) has launched its McValue 2.0 menu across the US, featuring an Under $3 Menu and new bundled meal deals. The company is pairing these offers with fresh pop culture collaborations, including KPop Demon Hunters themed meals. McDonald’s has also appointed new senior executives to strengthen its leadership team as affordability pressures remain in focus. For you as an investor, McDonald’s sits at the intersection of quick service dining, branding, and real estate, where...

Aeon (TSE:8267) has just closed FY 2026 with fourth quarter revenue of ¥2.97t and basic EPS of ¥30.22, alongside trailing 12 month revenue of ¥10.72t and EPS of ¥26.87, giving investors a clear read on the latest top and bottom line profile. Over recent periods, the company has seen quarterly revenue move from ¥2.66t in FY 2025 Q4 to ¥2.56t in Q1, ¥2.62t in Q2, ¥2.56t in Q3 and ¥2.97t in Q4 of FY 2026. Basic EPS has ranged from a loss of ¥8.23 in FY 2025 Q3 to a profit of ¥30.22 most...

Atlassian (NasdaqGS:TEAM) has launched new AI capabilities in Confluence, including an open beta of Remix, a tool that turns static text into visual stories. The company has also introduced pre-built third party agents that connect Confluence with partner apps such as Lovable, Replit, and Gamma for automatic content transformation and workflow integration. For Atlassian, known for collaboration products like Confluence and Jira, this move pushes its core knowledge product toward a more...

Recent performance snapshot for Stewart Information Services With no single headline event driving attention, Stewart Information Services (STC) has attracted interest based on its recent share performance, including a 1.2% gain over the past day and 7.8% over the past week. See our latest analysis for Stewart Information Services. That recent upswing comes after a softer patch, with the share price showing a 4.9% decline over three months and a 6.8% decline year to date, while longer term...

GSK (LSE:GSK) has received Chinese regulatory approval for Exdensur to treat chronic rhinosinusitis with nasal polyps in adults. Exdensur is described as the first ultra long acting biologic approved in China for this condition. The therapy is indicated for patients who do not respond adequately to conventional treatments. The approval follows positive Phase III trial results and provides a twice yearly treatment option. For you as an investor, this approval adds another product to GSK’s...

Warabeya Nichiyo Holdings (TSE:2918) closed out FY 2026 with fourth quarter revenue of ¥56.1b and a basic EPS loss of ¥25.52, alongside trailing twelve month revenue of ¥233.8b and EPS of ¥307.31 that reflects earnings growth of 99.3% over the past year. Over recent periods the company has seen quarterly revenue move from ¥53.2b in FY 2025 Q4 to ¥62.1b in FY 2026 Q2, while quarterly EPS has ranged from a loss of ¥54.96 to a gain of ¥142.60. This performance provides the backdrop for reported...

Harmony Biosciences Holdings (HRMY) is in focus after appointing Peter Anastasiou as Chief Operating Officer, adding Troy Ignelzi to the Board, and nominating Geno J. Germano for election at the 2026 shareholder meeting. See our latest analysis for Harmony Biosciences Holdings. The recent leadership reshuffle comes as Harmony Biosciences trades at US$29.16, with a 7 day share price return of 5.12% contrasting with a 90 day share price decline of 24.36% and a relatively flat 1 year total...

Recent performance snapshot for Rio Tinto Group Rio Tinto Group (LSE:RIO) has attracted fresh attention after recent trading, with the share price at £72.48 and total returns of 6% over the past month and 21.1% year to date. Over the past 3 months the stock has returned 20.7%, contributing to a 1 year total return of 81.2%. Over longer periods, 3 year and 5 year total returns of 57.4% and 79.3% show how the position has evolved for existing shareholders. See our latest analysis for Rio Tinto...

In early April 2026, semiconductor materials supplier Entegris benefited as the de-escalation of the U.S.-Iran conflict reopened the Strait of Hormuz, a key route for noble gases and other inputs used in chip fabrication. This development directly reinforces Entegris’ role in securing critical materials integrity for advanced semiconductor manufacturing, at a time when hedge fund interest highlights its importance in the supply chain. We’ll now examine how restored access to critical...

In late March 2026, a Chicago jury ordered Abbott Laboratories to pay US$53 million in compensatory damages to families alleging the company failed to adequately warn that its cow’s milk-based formula for premature infants could cause necrotizing enterocolitis, a potentially deadly bowel disease. This verdict, with punitive damages still to be determined, raises fresh questions about Abbott’s legal exposure, brand perception in infant nutrition, and the potential long-term impact on its...

KOMEDA Holdings (TSE:3543) has wrapped up FY 2026 with fourth quarter revenue of ¥14.8b and basic EPS of ¥38.45, setting the tone for a year where trailing twelve month revenue reached ¥57.2b and EPS came in at ¥141.99. Over recent periods, the company has seen quarterly revenue move from ¥12.4b in FY 2025 Q4 to ¥14.8b in FY 2026 Q4, with basic EPS shifting from ¥30.47 to ¥38.45 alongside trailing twelve month net income of ¥6.5b. This puts the latest report in clear focus for anyone tracking...

Eli Lilly's oral GLP-1 obesity pill Foundayo is beginning a broad U.S. launch via Amazon Pharmacy, GoodRx, Ro, Weight Watchers, and LillyDirect. The rollout uses multiple direct-to-consumer and digital health channels, with a focus on home delivery, self-pay options, and integrated clinical support. The move is intended to expand access to oral GLP-1 treatments and could influence how patients obtain and manage obesity therapies. Eli Lilly, traded as NYSE:LLY, is positioning Foundayo as a...